Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurotune launches sarcopenia test to speed up own drug development

This article was originally published in Clinica

Executive Summary

Biotech firm Neurotune has launched for research use a diagnostic for sarcopenia, a muscle loss disorder. It believes the test will help accelerate the development of its own pipeline of drugs for the disease. The test, which the firm claims is the first available for sarcopenia, could help to stratify patients, thereby allowing more targeted clinical trials. It could eventually be marketed as a companion diagnostic for use alongside these drugs, if approved.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098615

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel